AR
Advisory Research’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,893
| Closed | -$405K | – | 414 |
|
|
2022
Q1 | $405K | Buy |
4,893
+1,835
| +60% | +$152K | 0.03% | 272 |
|
|
2021
Q4 | $230K | Sell |
3,058
-8,036
| -72% | -$604K | 0.02% | 296 |
|
|
2021
Q3 | $1.29M | Sell |
11,094
-7,046
| -39% | -$819K | 0.08% | 169 |
|
|
2021
Q2 | $4.02M | Sell |
18,140
-657
| -3% | -$146K | 0.27% | 96 |
|
|
2021
Q1 | $2.49M | Sell |
18,797
-6,812
| -27% | -$901K | 0.18% | 115 |
|
|
2020
Q4 | $4.43M | Sell |
25,609
-16,347
| -39% | -$2.83M | 0.32% | 82 |
|
|
2020
Q3 | $4.67M | Buy |
41,956
+8,584
| +26% | +$955K | 0.46% | 69 |
|
|
2020
Q2 | $1.98M | Sell |
33,372
-3,934
| -11% | -$233K | 0.18% | 111 |
|
|
2020
Q1 | $2.51M | Sell |
37,306
-3,312
| -8% | -$223K | 0.17% | 74 |
|
|
2019
Q4 | $3.42M | Buy |
40,618
+15,094
| +59% | +$1.27M | 0.16% | 84 |
|
|
2019
Q3 | $1.91M | Sell |
25,524
-49,237
| -66% | -$3.68M | 0.09% | 128 |
|
|
2019
Q2 | $4.73M | Buy |
74,761
+12,344
| +20% | +$780K | 0.09% | 127 |
|
|
2019
Q1 | $3.01M | Sell |
62,417
-3,741
| -6% | -$180K | 0.06% | 153 |
|
|
2018
Q4 | $2.22M | Sell |
66,158
-27,314
| -29% | -$914K | 0.05% | 178 |
|
|
2018
Q3 | $4.9M | Sell |
93,472
-41,238
| -31% | -$2.16M | 0.08% | 140 |
|
|
2018
Q2 | $4.22M | Buy |
134,710
+18,400
| +16% | +$576K | 0.07% | 161 |
|
|
2018
Q1 | $2.54M | Buy |
116,310
+12,501
| +12% | +$273K | 0.05% | 195 |
|
|
2017
Q4 | $2.1M | Sell |
103,809
-7,500
| -7% | -$152K | 0.03% | 216 |
|
|
2017
Q3 | $2.21M | Buy |
111,309
+30,241
| +37% | +$600K | 0.04% | 208 |
|
|
2017
Q2 | $1.4M | Buy |
+81,068
| New | +$1.4M | 0.02% | 274 |
|